Smad2 mRNA expression has been found reduced in 22% of cervical carcinomas, as compared to normal cervix [29], while another study reported “weak” Smad2 protein levels in 33% of cervical tumors [30]. The gene discussed is SMAD2; the disease is uterine cervix neoplasm.